I was thinking of Rhinomed, Somnomed but yes FPH is a good company and in a similar vein to RMD, Sleep Apnea and related products. FPH has come off a fair bit too, from around $7.10 to 5.70 pretty dramatically and on no news to speak of.
Resmed enjoys 'first to market' advantage in many countries.
Michael McCarthy (CMC Markets) is not buying at the moment but made an exception for Resmed on Switzer a few minutes ago.
DYOR
Where does this end?, page-42
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
